If you have been curious about trying CBD gummies but you are not sure where to begin, we are here to guide you through the delicious world of flavours available in CBD gummies. Although CBD has been gaining attention day by day for its popularity due to its relaxing properties and health advantages.
CBD Patches are adhesive strips infused with cannabidiol, applied directly to the skin. These patches slowly release CBD through the skin, offering consistent support throughout the day. CBD Patches are greatest choice for individuals seeking targeted relief, especially if they prefer not to take CBD by mouth or dislike its taste.
We offer a variety of high-quality CBD Patches products designed to fit your lifestyle and wellness needs. Our selection has something for everyone, regardless of experience level with CBD.
Let’s look at why these CBD patches are a great way to support your overall wellness.
30mg CBD Patches – Gentle Relief for Beginners
If you’re new to CBD or just want a gentle boost, the 30mg patch is a great starting point. It provides a mild, steady release of CBD throughout the day to help with everyday de-stress, mild discomfort, or general relaxation.
CBD Patches 50mg — Balanced Strength for Daily Wellness
If you are looking for something a bit stronger then 50mg CBD patch offers a balanced dose that’s great for regular users who want consistent relief from moderate discomfort, nervousness, or wake cycle issues. It’s ideal if you need more noticeable effects but still want a manageable dose for all-day calm and comfort.
CBD Patches 70mg — Maximum Strength for Targeted Relief
For those needing serious support, the 70mg patch delivers a higher dose of CBD designed to help with intense soreness, chronic conditions, or significant unease and serious illness. It’s perfect if you’re experienced with CBD or need a powerful, long-lasting solution for deep relaxation and relief.
CBD Patches for Menopause – 30mg Daily Natural Relief
Due to large qualities of CBD (cannabidiol), menopause CBD patches provide a host of health advantages. Hot flashes and night sweats are common menopausal symptoms that CBD may help lessen in frequency and intensity.
Each patch delivers a gentle, steady dose of CBD over 24 hours—helping to ease hot flashes, mood swings, night sweats, and overall hormonal imbalance.
Spot & Blemish CBD Patches 30mg – Clear Skin, Naturally
Our Spot & Blemish CBD Patches (30mg) are a simple, effective way to target breakouts and calm irritated skin—right at the source. Infused with 30mg of high-quality CBD, each patch helps reduce redness, inflammation, and swelling associated with spots and blemishes.
How CBD Patches Work and What They Do
If you're interested in using it to reduce discomfort or inflammation in a particular area of your body. A CBD patch delivers the compound directly through the skin in a targeted area. This method is ideal for those people who prefer not to ingest or inhale CBD.
In addition, patches are less messy than other topicals. This method may provide long-lasting relief by releasing CBD gradually over several hours.
What CBD Patches Can Help With:
Relieve discomfort and inflammation
Reduce soreness and calm nerves
Improve sleep quality
Support skin troubles and issues
Help balance hormones (e.g., during menopause)
CBD patches are convenient, mess-free alternative to oils, gummies, or capsules—perfect for anyone looking for consistent and targeted wellness support throughout the day or night.
Apart from that, we have also stock of Wellness Patches that are designed to support your overall health and well-being—naturally and effortlessly. The speciality of these wellness patches for treating various medical issues. Wellness patches may reduce the possibility of stomach discomfort or digestive issues, which are frequently linked to some oral supplements, by providing nutrients through the skin.
Conclusion
CBD patches offer a discreet, fast-acting, and effective way to experience the wellness benefits of cannabidiol. They offer consistent, long-lasting assistance without requiring regular dosage by releasing CBD straight through the skin and into the bloodstream.
Whether you're seeking targeted relief, all-day relaxation, or a convenient alternative to traditional supplements, CBD patches are a dependable and user-friendly option.
A new paper adds to growing calls for urgent improvements in police training on how to respond to patients prescribed cannabis-based medicines. The research explores how regulations introduced in 2018, making it legal for specialists to prescribe medical cannabis, have not been ‘consistently implemented’, or ‘adequately [...]
As the industry clings to the hope of rescheduling, legal chaos continues to intensify after Congress moved to close the hemp loophole. The new language, set to take effect next October, has many hemp beverage and edible companies scrambling for a Plan B. While the intent [...]
The Medical Cannabis Clinicians Society (MCCS) has released a landmark guide setting out standardised dosing protocols for cannabis oils, in what the organisation describes as a major step forward for safe, consistent prescribing across the UK. The publication, which officially launched at the Cannabis Health Symposium [...]
The path cannabis is on isn’t new. The craft beer world walked it first, turning small, hands-on operations into efficient producers without losing their character. The lesson then, as now, was that passion alone doesn’t scale. Craft beer’s early boom wasn’t just cultural, it was operational. [...]
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK. These in-depth talks spanned everything from pharmacy standards and product quality to the specific challenges [...]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s collective drive to push beyond its own barriers and reach out to the wider medical community [...]
The experience in both wine and cannabis starts with ritual: swirling, inhaling, letting heat or air coax the plant’s chemistry to life. Where wine has long relied on sommeliers to guide that moment, cannabis has spent decades without an equivalent voice to explain how cultivation, curing, [...]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really [...]
In cannabis, everything begins with genetics. Before lighting, curing, irrigation, or any cultivation technique, there is the seed. And within that seed lives more than chemistry. It holds history, culture, and potential. Genetics are the soul of cannabis. They determine whether a cultivar expresses citrus or [...]
Medical Cannabis Awareness Week has expanded for 2025, with an entire month of momentum-building events and educational initiatives, as organisations in the sector mark seven years since the law change. Over the last few years, Medical Cannabis Awareness Week has become an important date in the [...]
Banking for cannabis businesses has come a long way. Ten years ago, most banks wouldn’t even consider it. Conversations would stop almost as soon as they began. “Too risky,” they’d say. “Too unclear.” Or, “Maybe someday, but not now.” Fast forward to today, and Green Check [...]
The recent Business of Cannabis Summit in New York City brought together industry professionals at the trendy Wythe Hotel in Williamsburg, Brooklyn, for a day focused on tackling the cannabis industry’s toughest challenges: price compression, retail survival, and the slow but steady shift from legacy to [...]
With shifting perceptions, economic incentives, and the evolution of international regulatory frameworks, more countries around the world are starting to embrace legal cannabis for its medical and recreational uses. One of the hotspots of legalization remains the European Union, where countries like Malta and Luxembourg have [...]
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still needed. This month, Releaf Cannabis Clinic published one of the most comprehensive surveys of UK medical [...]
Most cannabis operators I meet are juggling a lot more than they expected. One day they’re handling payroll, the next they’re sorting out compliance, and somehow still trying to grow the business. HR usually gets squeezed somewhere in between. It’s not that owners don’t care about [...]
There was no more fitting venue for a cannabis industry gathering than the Museum of the American Revolution in Philadelphia. The historic setting served as the backdrop for the Accelerate Cannabis Summit, a groundbreaking event that brought together cannabis leaders, entrepreneurs, and government officials from across [...]
Medical cannabis patients made history with a patient-led educational event about cannabis-based medicines, held at the Charterhouse in London. The international patient-led organisation We, The Patients, brought its educational event series to London for the first time on Friday 7 November, in partnership with PatientsCann UK, [...]
A panel discussion at the recent Business of Cannabis event in NYC analyzed the serious issues still facing the industry rollout in New York. What has been touted as a social equity-first initiative has been riddled with significant challenges and lawsuits. To date, the Office of [...]
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of [...]
For the first time, cannabis brands can claim airtime right alongside household names like Nike and Home Depot. Streaming platforms are serving Fortune 500 advertisers every hour, and now compliant cannabis companies are joining the lineup. This article breaks down how Connected TV (CTV) unlocks new [...]
The highlight of the Business of Cannabis event, held at the Wythe Hotel in Williamsburg, a hip neighborhood in Brooklyn, New York, was the keynote speaker. Ethan Nadelmann, founder of the Drug Policy Alliance, has since retired from his position but continues to mentor and serve [...]
This has been a whirlwind year in Washington, D.C., with the inauguration of President Donald Trump and the swearing in of a new Republican majority in the U.S. Senate. The “Republican trifecta” of the House, Senate, and administration has led to stalled progress with cannabis legalization, [...]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
A large UK study suggests that people who use cannabis to self-medicate for pain or anxiety may be more likely to experience paranoia, prompting calls for improved patient monitoring in private prescribing. Researchers from King’s College London recently published the first findings from the Cannabis & [...]
At the recent Business of Cannabis event in New York, Robert Sciarrone, Chief Revenue Officer at Curaleaf, shared an MSO’s insider view on why he believes New York is poised to become the best cannabis market on the planet. Sciarrone began by reflecting on his early [...]
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? In the face of long NHS waiting lists and a lack of options in mainstream healthcare, [...]
Families have marked the seventh anniversary of the legalisation of medical cannabis in the UK with further calls for urgent government action on NHS access. Dozens of families attended Westminster on Tuesday (4 November) to meet with cross-party MPs and demand immediate action to address the [...]
Cannabis products are increasingly held to the same standards as food and pharmaceuticals, and that means verifying how their potency and composition change over time. Cannabis stability testing provides the data needed to establish reliable shelf life, confirm product consistency, and guide formulation optimization for improved [...]
As cannabis production scales and testing standards tighten, cultivators face increasing pressure to ensure their products are free from harmful microbes without compromising quality. Decontamination, the process of removing or killing microorganisms, has become a common step in post-harvest processing. Traditional methods come with trade-offs that [...]
The endocannabinoid system (ECS) helps regulate vital bodily functions from mood and pain to immune response, yet it remains one of medicine’s best-kept secrets. We unpack the science behind the ECS and its significance in a range of chronic conditions. The endocannabinoid system (ECS) plays a [...]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in reducing illicit sales and promoting safer consumption. The move comes as the Swiss Federal Government continues [...]
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development (CPD)-accredited event, meaning attendees can earn professional development credits as a result of their participation. The [...]
MariMed, one of the nation’s leading multi-state cannabis operators, began in the medical cannabis market and expanded into adult-use as states legalized. Through this growth, the company has remained true to its “medical-first” approach, ensuring that product quality, safety, and consistency remain at the core of [...]
For decades, cannabis has lived in a research dead zone. Federal prohibition has blocked meaningful grants, limited clinical trials, and left millions of people with cancer relying on anecdotal evidence for treatment rather than data. As founders of E.R.I.C. Cancer Playbook, we refused to accept that. [...]
Jason Ambrosino, a disabled Army veteran and founder of Veterans Holdings, entered the New York market in 2019 under the state’s hemp program with the goal of cultivating and manufacturing cannabis. But despite holding a 5,000-square-foot indoor cultivation license, he decided not to build out his [...]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) Specialist Register have the training required to prescribe medical cannabis. While the UK’s medical cannabis market [...]
A growing number of patients are now prescribed medical cannabis for common mental health issues and neurodiverse conditions, such as autism and ADHD. Ahead of Cannabis Health Symposium next month, we examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry. Many [...]
A new health-tech company, EM2P2, has launched CannaLnx, a HIPAA-compliant platform it claims will make medical cannabis reimbursable under traditional health insurance plans for the first time in the U.S. The system, announced in partnership with the American Council of Cannabis Medicine (ACCM), is described as [...]
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025 at Conway Hall, London. The event, delivered in partnership with the Medical Cannabis Clinicians Society (MCCS), will focus on strengthening clinical understanding and confidence in prescribing [...]
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in [...]
Most cannabis dispensaries are small businesses. That often means they operate on tight margins and require employees to take on roles outside their typical job descriptions. It’s common for owners or general managers to handle HR and payroll functions themselves. What begins as an understandable cost-saving measure, however, [...]
Multiple scientific studies and lab results have provided compelling evidence that terpenes and volatile metabolites in cannabis rapidly degrade when exposed to light, oxygen, heat, and time, and therefore, reduce the entourage effect that depends on a specific balance of cannabinoids and terpenes. Because of this, [...]
How one oncologist is helping redefine patient care and the future of integrated healthcare. Medical cannabis is starting to have a very different kind of conversation in the UK. From mainstream voices like Rory Cellan-Jones exploring patient experiences on his Movers & Shakers podcast, to growing [...]
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, its VER-01 chronic pain-relief drug has passed a Phase 3 trial in its home market. As [...]
As the prevalence of dementia and other neurodegenerative conditions continues to rise globally, there is growing interest in the role of cannabis-based medicines in symptom management. A small number of studies, combined with real-world clinical experience is beginning to provide important insights into the potential of [...]
Target’s decision to start selling hemp-derived THC beverages marks a major milestone for the cannabis industry and a reality check for brands hoping to follow. Selling into mass retail is not just about scaling production or packaging appeal. It requires proving that your product meets the [...]
Medical cannabis patients will host a major educational event in the UK next month, aiming to bridge the gap between patients and healthcare professionals through evidence, empathy and lived experience. The international patient-led organisation We, The Patients, will bring its educational series to London next month [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
